Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Challenges and Strategic Approaches to Biosimilar Development
Track : Track 02: Project/Portfolio Management and Strategic Planning
Program Code: 343
Date: Wednesday, June 26, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 104AB
CHAIR :
 Jayanthi Reddy, MBA,MS,PMP (SCHNON), Director and Biologics Pipeline Leader,Global Project Management, Merck & Co., Inc., United States
SPEAKER (S):
Qinghai Zhao, (SPKNON), Director, Protein Sciences, Teva BioPharmaceuticals USA, United States
 Andrew J Rankin, (SPKNON), Vice President, Biopharmaceuticals, Prescient Life Sciences, United States
 Steve Farrand, PhD,MSc (SPKNON), Vice President and Head Bioprocess Development, Merck Research Laboratories, United States
Description
This session will focus on understanding the strategic questions companies are facing when developing biosimilars and the drug development approaches that are being adopted. Case studies will be provided followed by an open forum discussion.

Session Recording
(Code: 343)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 343)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Challenges and Strategic Approaches to Biosimilar Development